$OPCH
Option Care Health, Inc.

2014 Q4 Form 10-Q Financial Statement

#000101473914000016 Filed on November 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2014 Q1
Revenue $239.7M $244.0M $239.3M
YoY Change 6.32% 27.97% 32.12%
Cost Of Revenue $170.9M $170.7M $174.2M
YoY Change 8.65% 32.34% 39.19%
Gross Profit $63.68M $62.69M $62.14M
YoY Change -6.63% 1.67% 10.99%
Gross Profit Margin 26.56% 25.7% 25.97%
Selling, General & Admin $87.70M $82.20M $65.80M
YoY Change 26.55% 46.52% 31.34%
% of Gross Profit 137.72% 131.13% 105.89%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.700M $4.205M $3.836M
YoY Change -10.53% 30.39% 58.64%
% of Gross Profit 2.67% 6.71% 6.17%
Operating Expenses $105.2M $83.70M $65.30M
YoY Change 59.88% 47.88% 25.1%
Operating Profit -$41.52M -$27.71M -$11.27M
YoY Change -1832.97% 3927.18% 415.13%
Interest Expense -$9.300M $9.563M $10.50M
YoY Change 16.25% 33.13% 62.07%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$60.63M -$37.27M -$23.61M
YoY Change 365.96% 56.82% 176.48%
Income Tax $2.700M $1.930M $3.491M
% Of Pretax Income
Net Earnings -$63.63M -$38.71M -$25.31M
YoY Change 242.83% 13.56% 211.44%
Net Earnings / Revenue -26.54% -15.87% -10.58%
Basic Earnings Per Share -$0.57 -$0.37
Diluted Earnings Per Share -$3.698M -$2.250M -$1.480M
COMMON SHARES
Basic Shares Outstanding 68.64M shares 68.62M shares 68.17M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q4 2014 Q3 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $700.0K $0.00 $9.300M
YoY Change -30.0%
Cash & Equivalents $740.0K $0.00 $9.253M
Short-Term Investments
Other Short-Term Assets $18.70M $11.10M $12.30M
YoY Change -36.39% -16.54% 35.16%
Inventory $37.22M $33.78M $34.75M
Prepaid Expenses
Receivables $140.8M $170.6M $195.1M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $188.2M $215.6M $251.3M
YoY Change -20.57% -2.95% 32.27%
LONG-TERM ASSETS
Property, Plant & Equipment $38.17M $40.05M $39.95M
YoY Change -7.31% -2.44% 43.89%
Goodwill $573.3M $573.3M $571.8M
YoY Change 0.35% -5.34% 38.05%
Intangibles $10.27M $11.88M $15.12M
YoY Change -38.96% -65.15% -21.91%
Long-Term Investments
YoY Change
Other Assets $1.272M $1.275M $3.576M
YoY Change -65.93% -71.58% 158.19%
Total Long-Term Assets $636.5M $643.3M $648.7M
YoY Change -9.06% -8.65% 36.38%
TOTAL ASSETS
Total Short-Term Assets $188.2M $215.6M $251.3M
Total Long-Term Assets $636.5M $643.3M $648.7M
Total Assets $824.7M $858.8M $900.1M
YoY Change -11.97% -7.28% 35.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $89.20M $74.85M $68.29M
YoY Change 40.31% 48.86% 112.68%
Accrued Expenses $53.80M $39.90M $45.00M
YoY Change 39.74% 5.0% -8.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.395M $4.900M $400.0K
YoY Change -91.05% -86.12% -98.57%
Total Short-Term Liabilities $163.3M $135.5M $127.6M
YoY Change -7.41% 1.48% -4.2%
LONG-TERM LIABILITIES
Long-Term Debt $418.4M $418.4M $418.2M
YoY Change 11.48% 10.02% 85.54%
Other Long-Term Liabilities $8.129M $8.255M $8.940M
YoY Change -53.65% -72.85% -0.35%
Total Long-Term Liabilities $8.129M $8.255M $8.940M
YoY Change -97.93% -72.85% -0.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $163.3M $135.5M $127.6M
Total Long-Term Liabilities $8.129M $8.255M $8.940M
Total Liabilities $607.9M $580.3M $567.4M
YoY Change 4.4% 4.38% 50.01%
SHAREHOLDERS EQUITY
Retained Earnings -$302.2M -$238.6M -$180.1M
YoY Change 95.3% 75.2% 93.16%
Common Stock $529.7M $527.4M $523.0M
YoY Change 1.94% 2.05% 33.77%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.68M $10.31M $10.31M
YoY Change 3.57% 0.0% 0.0%
Treasury Stock Shares 2.637M shares 2.583M shares 2.583M shares
Shareholders Equity $216.6M $278.5M $332.7M
YoY Change
Total Liabilities & Shareholders Equity $824.7M $858.8M $900.1M
YoY Change -11.97% -7.28% 35.2%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2014 Q1
OPERATING ACTIVITIES
Net Income -$63.63M -$38.71M -$25.31M
YoY Change 242.83% 13.56% 211.44%
Depreciation, Depletion And Amortization $1.700M $4.205M $3.836M
YoY Change -10.53% 30.39% 58.64%
Cash From Operating Activities $300.0K -$700.0K -$25.99M
YoY Change -101.84% -95.68% 102.26%
INVESTING ACTIVITIES
Capital Expenditures -$2.500M -$4.400M -$3.100M
YoY Change -55.36% -50.56% -13.89%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $900.0K $0.00 $56.60M
YoY Change -57.14% -100.0% -177.22%
Cash From Investing Activities -$1.600M -$4.400M $53.56M
YoY Change -55.56% -98.01% -169.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.100M 3.600M -$19.32M
YoY Change -89.9% -97.69% -169.92%
NET CHANGE
Cash From Operating Activities 300.0K -700.0K -$25.99M
Cash From Investing Activities -1.600M -4.400M $53.56M
Cash From Financing Activities 2.100M 3.600M -$19.32M
Net Change In Cash 800.0K -1.500M $8.252M
YoY Change -11.11% -98.16% -113.29%
FREE CASH FLOW
Cash From Operating Activities $300.0K -$700.0K -$25.99M
Capital Expenditures -$2.500M -$4.400M -$3.100M
Free Cash Flow $2.800M $3.700M -$22.89M
YoY Change -126.17% -150.68% 147.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
1800000 USD
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-613000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8218000 USD
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
74849000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
63575000 USD
CY2013Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
190023000 USD
CY2014Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
209873000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
172187000 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170633000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42016000 USD
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
52522000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
519625000 USD
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
527410000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
4943000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
4801000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
17836000 USD
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
39240000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
17836000 USD
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
39240000 USD
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
21400000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2013Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2014Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
132000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
327000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3280000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1410000 USD
CY2014Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
730000 USD
CY2013Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
688000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1410000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3607000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4943000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4801000 USD
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1620000 USD
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1009000 USD
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6300000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6300000 shares
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3800000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4200000 shares
CY2014Q3 us-gaap Assets
Assets
858843000 USD
CY2013Q4 us-gaap Assets
Assets
936858000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
236955000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
215558000 USD
CY2014Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2013Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
15316000 USD
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
921000 USD
CY2014Q3 us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
600000 USD
CY2013Q3 us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
400000 USD
CY2013Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
576000 USD
CY2014Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
696000 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
735000 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
122000 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
11000 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
62000 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
122000 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
418000 USD
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0 USD
us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
1000000 USD
CY2014Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
16686000 USD
CY2013Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
13746000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1001000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62101000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-62101000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1001000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
57677000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-48000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-5074000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-9322000 USD
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71218985 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70711439 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68636465 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68128919 shares
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
7000 USD
CY2014Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
3566000 USD
CY2013Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
8815000 USD
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
178957000 USD
us-gaap Cost Of Revenue
CostOfRevenue
534919000 USD
us-gaap Cost Of Revenue
CostOfRevenue
368557000 USD
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
128976000 USD
CY2014Q3 us-gaap Cost Of Services
CostOfServices
16832000 USD
us-gaap Cost Of Services
CostOfServices
44734000 USD
CY2013Q3 us-gaap Cost Of Services
CostOfServices
13411000 USD
us-gaap Cost Of Services
CostOfServices
59396000 USD
CY2013Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
287000 USD
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
266000 USD
CY2014Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
70000 USD
CY2013Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-91000 USD
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-1135000 USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-522000 USD
CY2013Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-378000 USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
266000 USD
CY2014Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
70000 USD
CY2013Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
275000 USD
CY2014Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1653000 USD
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1160000 USD
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
7297000 USD
CY2014Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1100000 USD
CY2013Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
17184000 USD
CY2014Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
16757000 USD
CY2014Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1860000 USD
CY2013Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
78000 USD
CY2013Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-197000 USD
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-67000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1093000 USD
CY2013Q3 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
15000000 USD
CY2014Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
207000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
8954000 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
18187000 USD
CY2013Q2 us-gaap Deposit Assets
DepositAssets
1100000 USD
CY2014Q3 us-gaap Deposit Assets
DepositAssets
500000 USD
us-gaap Depreciation
Depreciation
8169000 USD
us-gaap Depreciation
Depreciation
11999000 USD
CY2014Q3 us-gaap Depreciation
Depreciation
4205000 USD
CY2013Q3 us-gaap Depreciation
Depreciation
3225000 USD
CY2014Q3 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0 USD
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
6550000 USD
CY2013Q3 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
6543000 USD
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0 USD
CY2014Q3 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
0 USD
us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
0 USD
us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
15000000 USD
CY2014Q3 us-gaap Disposal Group Including Discontinued Operation Long Lived Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationLongLivedAssetsNoncurrent
0 USD
CY2013Q4 us-gaap Disposal Group Including Discontinued Operation Long Lived Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationLongLivedAssetsNoncurrent
49643000 USD
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.81
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16526000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21469000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1620000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1799000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3078000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5318000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
33350000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
33350000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11881000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16824000 USD
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4291000 USD
CY2014Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4469000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-15898000 USD
CY2013Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-15898000 USD
CY2014Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2014Q3 us-gaap Goodwill
Goodwill
573323000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
571337000 USD
us-gaap Goodwill Other Changes
GoodwillOtherChanges
1986000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
65002000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
61655000 USD
us-gaap Gross Profit
GrossProfit
175417000 USD
us-gaap Gross Profit
GrossProfit
195458000 USD
us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
323823000 USD
CY2013Q3 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
115565000 USD
us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
475523000 USD
CY2014Q3 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
162125000 USD
CY2013Q3 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
169011000 USD
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
667601000 USD
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
469594000 USD
CY2014Q3 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
226421000 USD
CY2013Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
21620000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
74380000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
62776000 USD
CY2014Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
17538000 USD
CY2014Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
243959000 USD
CY2013Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
190631000 USD
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
730377000 USD
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
543974000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-23756000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-41415000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-37575000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-81442000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-35645000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-23769000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-41457000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-72958000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.19
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.66
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.55
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.37
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2400000 USD
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1135000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-9680000 USD
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-10331000 USD
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.16
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.04
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.15
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-661000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-42000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1930000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-830000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8484000 USD
CY2013Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9206000 USD
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
15499000 USD
CY2014Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
14295000 USD
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
33651000 USD
CY2014Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-12464000 USD
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-14510000 USD
CY2013Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-8319000 USD
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-25508000 USD
CY2014Q3 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
54000 USD
CY2013Q3 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-503000 USD
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
168000 USD
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
220000 USD
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-756000 USD
CY2013Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-408000 USD
CY2014Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
43000 USD
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
168000 USD
CY2014Q3 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
2000 USD
us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-495000 USD
CY2013Q3 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
11000 USD
us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
5000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1692000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
242000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
8041000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
10837000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1393000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-8218000 USD
us-gaap Increase Decrease In Future Policy Benefit Reserves
IncreaseDecreaseInFuturePolicyBenefitReserves
6092000 USD
us-gaap Increase Decrease In Future Policy Benefit Reserves
IncreaseDecreaseInFuturePolicyBenefitReserves
-5275000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
436000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-3832000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-486000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8875000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-4435000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-561000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5774000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
20655000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-827000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16824000 USD
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11881000 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
7183000 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
9563000 USD
us-gaap Interest Expense
InterestExpense
29197000 USD
us-gaap Interest Expense
InterestExpense
20169000 USD
CY2014Q3 us-gaap Interest Expense Other
InterestExpenseOther
-58000 USD
CY2013Q3 us-gaap Interest Expense Other
InterestExpenseOther
19000 USD
us-gaap Interest Expense Other
InterestExpenseOther
-100000 USD
us-gaap Interest Expense Other
InterestExpenseOther
-70000 USD
CY2013Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2173000 USD
CY2014Q3 us-gaap Inventory Net
InventoryNet
33777000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
34341000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
5900000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
5600000 USD
CY2014Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2000000 USD
CY2013Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2000000 USD
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
12082000 USD
CY2014Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
13215000 USD
CY2014Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9563000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
20169000 USD
CY2013Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7183000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
29197000 USD
us-gaap Interest Paid Net
InterestPaidNet
22598000 USD
us-gaap Interest Paid Net
InterestPaidNet
25328000 USD
CY2014Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2608000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
582275000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
580316000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
858843000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
936858000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
174306000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
135519000 USD
CY2013Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
6576000 USD
CY2014Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2013Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
6153000 USD
CY2014Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
418355000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
375322000 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
4925000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
60257000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15160000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
274968000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
45904000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-298807000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-11773000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-298759000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38262000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31745000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1098000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-26671000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-28940000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-38710000 USD
us-gaap Net Income Loss
NetIncomeLoss
-51095000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-34087000 USD
us-gaap Net Income Loss
NetIncomeLoss
-83842000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5390000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-26082000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-688000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-43761000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
31937000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2265000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
3987000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
5775000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
6785000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
8332000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4793000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1275000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3733000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17540000 USD
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8255000 USD
CY2013Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
52454000 USD
CY2014Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
58702000 USD
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
149671000 USD
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
175126000 USD
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
0 USD
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
2348000 USD
CY2013Q2 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-8500000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
19881000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
11319000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2115000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
285039000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
454000 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11148000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14110000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
118570000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1885000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
205700000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
379896000 USD
us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
0 USD
us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
-172243000 USD
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 USD
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
8509000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
399000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
83198000 USD
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
92571000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41182000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40049000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10265000 USD
CY2013Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3624000 USD
CY2014Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
26080000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
41041000 USD
CY2014Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
170633000 USD
CY2013Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
172187000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
364859000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
241203000 USD
CY2013Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
21000000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
248000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
809000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
237397000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 USD
CY2013Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
1100000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
1500000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
2400000 USD
CY2014Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
200000 USD
CY2014Q3 us-gaap Restructuring Charges
RestructuringCharges
1846000 USD
us-gaap Restructuring Charges
RestructuringCharges
10296000 USD
us-gaap Restructuring Charges
RestructuringCharges
3457000 USD
CY2013Q3 us-gaap Restructuring Charges
RestructuringCharges
778000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-238580000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-154738000 USD
CY2014Q1 us-gaap Revenues
Revenues
239300000 USD
us-gaap Revenues
Revenues
543974000 USD
CY2013Q3 us-gaap Revenues
Revenues
190631000 USD
CY2014Q3 us-gaap Revenues
Revenues
243959000 USD
us-gaap Revenues
Revenues
730377000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
5200000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
278527000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
354583000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6637000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7260000 USD
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1753000 USD
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1427000 USD
CY2013Q2 us-gaap Share Price
SharePrice
12
CY2013Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10406250 shares
CY2013Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
118600000 USD
CY2013Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1500000 USD
CY2014Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1800000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
4800000 USD
CY2013Q4 us-gaap Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves
SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves
2547000 USD
CY2014Q3 us-gaap Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves
SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves
8639000 USD
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2582520 shares
CY2014Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2582520 shares
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10311000 USD
CY2014Q3 us-gaap Treasury Stock Value
TreasuryStockValue
10311000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68421000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67912000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68615000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63368000 shares
CY2014Q3 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
37255000 USD
CY2013Q4 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
34352000 USD
CY2013Q3 bios Acquisition And Integration Expenses
AcquisitionAndIntegrationExpenses
4890000 USD
CY2014Q3 bios Acquisition And Integration Expenses
AcquisitionAndIntegrationExpenses
2922000 USD
bios Acquisition And Integration Expenses
AcquisitionAndIntegrationExpenses
13025000 USD
bios Acquisition And Integration Expenses
AcquisitionAndIntegrationExpenses
14754000 USD
bios Adjusted Ebitda
AdjustedEbitda
29948000 USD
CY2014Q3 bios Adjusted Ebitda
AdjustedEbitda
-4719000 USD
CY2014Q3 bios Future Minimum Payments Due
FutureMinimumPaymentsDue
32672000 USD
CY2014Q3 bios Future Minimum Payments Due Current
FutureMinimumPaymentsDueCurrent
2387000 USD
CY2014Q3 bios Future Minimum Payments Due In Five Years
FutureMinimumPaymentsDueInFiveYears
3998000 USD
CY2014Q3 bios Future Minimum Leases Due Thereafter
FutureMinimumLeasesDueThereafter
4793000 USD
CY2014Q3 bios Future Minimum Payments Due In Four Years
FutureMinimumPaymentsDueInFourYears
5837000 USD
CY2014Q3 bios Future Minimum Payments Due In Three Years
FutureMinimumPaymentsDueInThreeYears
6907000 USD
bios Adjusted Ebitda
AdjustedEbitda
56000000 USD
CY2013Q3 bios Adjusted Ebitda
AdjustedEbitda
18897000 USD
CY2013Q4 bios Allowancefor Doubtful Accounts Percentageof Accounts Receivable
AllowanceforDoubtfulAccountsPercentageofAccountsReceivable
0.094
CY2014Q3 bios Future Minimum Payments Due In Two Years
FutureMinimumPaymentsDueInTwoYears
8750000 USD
bios Gain Losson Changein Fair Valueof Contingent Consideration
GainLossonChangeinFairValueofContingentConsideration
412000 USD
bios Gain Losson Changein Fair Valueof Contingent Consideration
GainLossonChangeinFairValueofContingentConsideration
6941000 USD
CY2013Q3 bios Gain Losson Changein Fair Valueof Contingent Consideration
GainLossonChangeinFairValueofContingentConsideration
412000 USD
CY2014Q3 bios Gain Losson Changein Fair Valueof Contingent Consideration
GainLossonChangeinFairValueofContingentConsideration
86000 USD
CY2014Q3 bios Allowancefor Doubtful Accounts Percentageof Accounts Receivable
AllowanceforDoubtfulAccountsPercentageofAccountsReceivable
0.187
CY2013Q4 bios Amounts Due To Plan Sponsors
AmountsDueToPlanSponsors
4826000 USD
CY2014Q3 bios Amounts Due To Plan Sponsors
AmountsDueToPlanSponsors
7243000 USD
CY2013Q4 bios Computer And Office Equipment Gross
ComputerAndOfficeEquipmentGross
19961000 USD
CY2014Q3 bios Computer And Office Equipment Gross
ComputerAndOfficeEquipmentGross
23287000 USD
CY2012Q1 bios Disposal Group Including Discontinued Operation Proceeds
DisposalGroupIncludingDiscontinuedOperationProceeds
173800000 USD
CY2014Q3 bios Duefrom Saleof Affiliate Equity Investment Noncurrent
DuefromSaleofAffiliateEquityInvestmentNoncurrent
2400000 USD
CY2014Q3 bios Employee Stock Ownership Plan Shares Registered
EmployeeStockOwnershipPlanSharesRegistered
750000 shares
CY2014Q3 bios Finite Lived Intangible Assets Amortization Expense Year Fiveand Thereafter
FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveandThereafter
66000 USD
CY2014Q1 bios Income Lossfrom Continuing Operations Netof Taxes
IncomeLossfromContinuingOperationsNetofTaxes
25300000 USD
bios Increase Decreasein Amountsduetoplansponsor
IncreaseDecreaseinAmountsduetoplansponsor
-10254000 USD
bios Increase Decreasein Amountsduetoplansponsor
IncreaseDecreaseinAmountsduetoplansponsor
2417000 USD
bios Increase Decreasein Fair Valueof Contingent Consideration
IncreaseDecreaseinFairValueofContingentConsideration
6941000 USD
bios Increase Decreasein Fair Valueof Contingent Consideration
IncreaseDecreaseinFairValueofContingentConsideration
412000 USD
bios Increasein Accounts Receivable Outstandingover One Hundred Eight Days
IncreaseinAccountsReceivableOutstandingoverOneHundredEightDays
23000000 USD
bios Interestratelegalsettlement
Interestratelegalsettlement
0.0325
CY2013Q4 bios Long Term Debt And Capital Lease Obligations Total
LongTermDebtAndCapitalLeaseObligationsTotal
435579000 USD
CY2014Q3 bios Long Term Debt And Capital Lease Obligations Total
LongTermDebtAndCapitalLeaseObligationsTotal
423280000 USD
CY2014Q3 bios Medical Equipment Gross
MedicalEquipmentGross
29129000 USD
CY2013Q4 bios Medical Equipment Gross
MedicalEquipmentGross
22247000 USD
bios One Time Costs Related To Pharmacy Services Asset Sale Reserve Noncash
OneTimeCostsRelatedToPharmacyServicesAssetSaleReserveNoncash
95000 USD
bios One Time Costs Related To Pharmacy Services Asset Sale Reserve Settled In Cash
OneTimeCostsRelatedToPharmacyServicesAssetSaleReserveSettledInCash
6862000 USD
CY2014Q3 bios Onetimecostsrelatedtopharmacyservicesassetsalereserve
Onetimecostsrelatedtopharmacyservicesassetsalereserve
12846000 USD
CY2013Q4 bios Onetimecostsrelatedtopharmacyservicesassetsalereserve
Onetimecostsrelatedtopharmacyservicesassetsalereserve
16287000 USD
CY2013Q2 bios Proceedsfrom Issuanceof Common Stock Used To Fund Acquisition
ProceedsfromIssuanceofCommonStockUsedToFundAcquisition
61100000 USD
bios Restructuring Charges Other Expensesand Investments
RestructuringChargesOtherExpensesandInvestments
4604000 USD
CY2014Q3 bios Restructuring Charges Other Expensesand Investments
RestructuringChargesOtherExpensesandInvestments
2970000 USD
bios Restructuring Charges Other Expensesand Investments
RestructuringChargesOtherExpensesandInvestments
12991000 USD
CY2013Q3 bios Restructuring Charges Other Expensesand Investments
RestructuringChargesOtherExpensesandInvestments
1551000 USD
bios Restructuringcoststransactioncostsandotheronetimechargesasaresultofthetransaction
Restructuringcoststransactioncostsandotheronetimechargesasaresultofthetransaction
3516000 USD
CY2013Q2 bios Saleof Affiliate Equity Investment Period After Close Expectedto Receive Additional Servicesor Cash
SaleofAffiliateEquityInvestmentPeriodAfterCloseExpectedtoReceiveAdditionalServicesorCash
P2Y
bios Stock Appreciation Right Benefit Expense
StockAppreciationRightBenefitExpense
100000 USD
bios Stock Appreciation Right Benefit Expense
StockAppreciationRightBenefitExpense
-100000 USD
CY2013Q3 bios Stock Appreciation Right Benefit Expense
StockAppreciationRightBenefitExpense
-1300000 USD
CY2014Q3 bios Stock Appreciation Right Benefit Expense
StockAppreciationRightBenefitExpense
-300000 USD
CY2013Q2 bios Stock Issued During Period Shares Selling Stockholders
StockIssuedDuringPeriodSharesSellingStockholders
3968750 shares
bios Transitional Expenses
TransitionalExpenses
2300000 USD
CY2013Q3 bios Transitional Expenses
TransitionalExpenses
700000 USD
CY2014Q3 bios Transitional Expenses
TransitionalExpenses
700000 USD
bios Transitional Expenses
TransitionalExpenses
2700000 USD
CY2013Q4 bios Vehicles Gross
VehiclesGross
2056000 USD
CY2014Q3 bios Vehicles Gross
VehiclesGross
2219000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001014739
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68636465 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
BioScrip, Inc.

Files In Submission

Name View Source Status
0001014739-14-000016-index-headers.html Edgar Link pending
0001014739-14-000016-index.html Edgar Link pending
0001014739-14-000016.txt Edgar Link pending
0001014739-14-000016-xbrl.zip Edgar Link pending
bios-20140930.xml Edgar Link completed
bios-20140930.xsd Edgar Link pending
bios-20140930x10q.htm Edgar Link pending
bios-20140930_cal.xml Edgar Link unprocessable
bios-20140930_def.xml Edgar Link unprocessable
bios-20140930_lab.xml Edgar Link unprocessable
bios-20140930_pre.xml Edgar Link unprocessable
bios-ex311x20140930.htm Edgar Link pending
bios-ex312x20140930.htm Edgar Link pending
bios-ex321x20140930.htm Edgar Link pending
bios-ex322x20140930.htm Edgar Link pending
bioscriplogoa01a01a01a01a01.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending